false
OasisLMS
Login
Catalog
Expert Perspectives: Evolution of Implantable Tibi ...
Expert Perspectives: Evolution of Implantable Tibi ...
Expert Perspectives: Evolution of Implantable Tibial Neuromodulation (ITNM)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The webinar, hosted by AUGS and Medtronic, focused on the evolving role of implantable tibial neuromodulation (ITNM) for overactive bladder and urgency urinary incontinence. Drs. Vince Lucente, Siobhan Hartigan, and Umar Karaman shared real-world experience on why they adopted the therapy, emphasizing the large unmet need among patients who fail medications, dislike repeated procedures, lack transportation, or want a less invasive option than sacral neuromodulation.<br /><br />Key clinical themes included patient selection, with early adopters recommending starting with simpler cases and then expanding as comfort grows. The panel stressed holistic assessment: mobility, support, hand function, diabetes, edema, skin integrity, infection risk, and whether a patient can manage device recharge requirements. They also discussed practical pearls for the procedure, including patient positioning, meticulous foot prep, avoiding cautery, gentle tissue handling, and careful closure. The implant was described as simple, low burden, and highly customizable.<br /><br />Post-procedure expectations were also reviewed. Patients are generally told to be patient, with symptom improvement often appearing over 4–6 weeks. Device settings can be adjusted if needed, and follow-up is important to reassure patients and optimize outcomes.<br /><br />A major portion of the discussion addressed reimbursement. Wendy Chan outlined the current coding, coverage, and payment landscape, explaining that ITNM currently uses a Category III code with facility reimbursement available, while physicians often crosswalk to Category I codes for work RVU valuation. She also emphasized prior authorization, appeals, payer-specific documentation, and Medtronic’s support resources, including templates and patient access support.<br /><br />The panel concluded that ITNM is a valuable addition to shared decision-making and urged clinicians to engage early rather than wait on the sidelines.
Meta Tag
Concept
Implantable Tibial Neuromodulation
Concept
Refractory Urgency Incontinence
Concept
Overactive Bladder
Concept
Patient Selection
Concept
Medical Necessity Documentation
Keywords
implantable tibial neuromodulation
overactive bladder
urgency urinary incontinence
patient selection
shared decision-making
Category III code
prior authorization
reimbursement
sacral neuromodulation
patient access support
Implantable Tibial Neuromodulation
Refractory Urgency Incontinence
Overactive Bladder
Patient Selection
Medical Necessity Documentation
×
Please select your language
1
English